BHK Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,790
| Closed | -$399K | – | 65 |
|
|
2022
Q4 | $399K | Sell |
7,790
-1,548
| -17% | -$79.3K | 0.22% | 39 |
|
|
2022
Q3 | $409K | Sell |
9,338
-1,290
| -12% | -$56.5K | 0.21% | 40 |
|
|
2022
Q2 | $557K | Buy |
10,628
+619
| +6% | +$32.4K | 0.25% | 32 |
|
|
2022
Q1 | $518K | Buy |
10,009
+4
| +0% | +$207 | 0.22% | 33 |
|
|
2021
Q4 | $591K | Buy |
10,005
+4
| +0% | +$236 | 0.23% | 32 |
|
|
2021
Q3 | $430K | Sell |
10,001
-106
| -1% | -$4.56K | 0.18% | 40 |
|
|
2021
Q2 | $396K | Hold |
10,107
| – | – | 0.16% | 44 |
|
|
2021
Q1 | $372K | Buy |
10,107
+83
| +0.8% | +$3.06K | 0.17% | 43 |
|
|
2020
Q4 | $369K | Buy |
10,024
+95
| +1% | +$3.5K | 0.17% | 42 |
|
|
2020
Q3 | $346K | Buy |
9,929
+448
| +5% | +$15.6K | 0.19% | 39 |
|
|
2020
Q2 | $294K | Buy |
9,481
+1,421
| +18% | +$44.1K | 0.17% | 44 |
|
|
2020
Q1 | $250K | Sell |
8,060
-10,237
| -56% | -$318K | 0.18% | 43 |
|
|
2019
Q4 | $680K | Sell |
18,297
-2,148
| -11% | -$79.8K | 0.39% | 29 |
|
|
2019
Q3 | $697K | Buy |
20,445
+364
| +2% | +$12.4K | 0.4% | 40 |
|
|
2019
Q2 | $825K | Sell |
20,081
-855
| -4% | -$35.1K | 0.47% | 36 |
|
|
2019
Q1 | $844K | Buy |
20,936
+10,942
| +109% | +$441K | 0.51% | 32 |
|
|
2018
Q4 | $414K | Buy |
9,994
+1,222
| +14% | +$50.6K | 0.31% | 40 |
|
|
2018
Q3 | $367K | Buy |
8,772
+1,506
| +21% | +$63K | 0.25% | 49 |
|
|
2018
Q2 | $250K | Sell |
7,266
-343
| -5% | -$11.8K | 0.17% | 63 |
|
|
2018
Q1 | $256K | Sell |
7,609
-380
| -5% | -$12.8K | 0.19% | 55 |
|
|
2017
Q4 | $275K | Buy |
+7,989
| New | +$275K | 0.23% | 42 |
|